N-[(3R,6S)-6-(diethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-1,3-benzothiazol-6-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-(1,3-thiazol-2-ylcarbamoyl)piperidin-3-yl]-3-(2-methylindazol-5-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(3-fluoro-3-methylazetidine-1-carbonyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide

C159H171F3N32O12S2 — CID 158039940

IUPACN-[(3R,6S)-6-(diethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-1,3-benzothiazol-6-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-(1,3-thiazol-2-ylcarbamoyl)piperidin-3-yl]-3-(2-methylindazol-5-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(3-fluoro-3-methylazetidine-1-carbonyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide
SMILESCCN(CC)C(=O)[C@@H]1CC[C@@H](NC(=O)c2ccc3[nH]nc(-c4ccnc(C)c4)c3c2)CN1CCc1ccccc1.COc1cccc(F)c1CN1C[C@H](NC(=O)c2ccc3[nH]nc(-c4ccc5nc(C)sc5c4)c3c2)CC[C@H]1C(=O)N(C)C.COc1cccc(F)c1CN1C[C@H](NC(=O)c2ccc3[nH]nc(-c4ccc5nn(C)cc5c4)c3c2)CC[C@H]1C(=O)Nc1nccs1.Cc1cc(-c2n[nH]c3ccc(C(=O)N[C@@H]4CC[C@@H](C(=O)N(C)C)N(CCc5ccccc5)C4)cc23)ccn1.Cc1cc(-c2n[nH]c3ccc(C(=O)N[C@@H]4CC[C@@H](C(=O)N5CC(C)(F)C5)N(CCc5ccccc5)C4)cc23)ccn1
InChIInChI=1S/C33H31FN8O3S.C32H33FN6O3S.C32H35FN6O2.C32H38N6O2.C30H34N6O2/c1-41-16-21-14-19(6-9-26(21)40-41)30-23-15-20(7-10-27(23)38-39-30)31(43)36-22-8-11-28(32(44)37-33-35-12-13-46-33)42(17-22)18-24-25(34)4-3-5-29(24)45-2;1-18-34-26-12-8-19(15-29(26)43-18)30-22-14-20(9-11-25(22)36-37-30)31(40)35-21-10-13-27(32(41)38(2)3)39(16-21)17-23-24(33)6-5-7-28(23)42-4;1-21-16-23(12-14-34-21)29-26-17-24(8-10-27(26)36-37-29)30(40)35-25-9-11-28(31(41)39-19-32(2,33)20-39)38(18-25)15-13-22-6-4-3-5-7-22;1-4-37(5-2)32(40)29-14-12-26(21-38(29)18-16-23-9-7-6-8-10-23)34-31(39)25-11-13-28-27(20-25)30(36-35-28)24-15-17-33-22(3)19-24;1-20-17-22(13-15-31-20)28-25-18-23(9-11-26(25)33-34-28)29(37)32-24-10-12-27(30(38)35(2)3)36(19-24)16-14-21-7-5-4-6-8-21/h3-7,9-10,12-16,22,28H,8,11,17-18H2,1-2H3,(H,36,43)(H,38,39)(H,35,37,44);5-9,11-12,14-15,21,27H,10,13,16-17H2,1-4H3,(H,35,40)(H,36,37);3-8,10,12,14,16-17,25,28H,9,11,13,15,18-20H2,1-2H3,(H,35,40)(H,36,37);6-11,13,15,17,19-20,26,29H,4-5,12,14,16,18,21H2,1-3H3,(H,34,39)(H,35,36);4-9,11,13,15,17-18,24,27H,10,12,14,16,19H2,1-3H3,(H,32,37)(H,33,34)/t22-,28+;21-,27+;25-,28+;26-,29+;24-,27+/m11111/s1
InChIKeyFIFPFEGQJSTOPC-RCOOQGBVSA-N
MW2843.46 g/mol
LogP23.01
Rot. Bonds38

About N-[(3R,6S)-6-(diethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-1,3-benzothiazol-6-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-(1,3-thiazol-2-ylcarbamoyl)piperidin-3-yl]-3-(2-methylindazol-5-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(3-fluoro-3-methylazetidine-1-carbonyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide

N-[(3R,6S)-6-(diethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-1,3-benzothiazol-6-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-(1,3-thiazol-2-ylcarbamoyl)piperidin-3-yl]-3-(2-methylindazol-5-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(3-fluoro-3-methylazetidine-1-carbonyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide (PubChem CID 158039940) has the molecular formula C159H171F3N32O12S2 and a molecular weight of 2843.46 g/mol. Its IUPAC name is N-[(3R,6S)-6-(diethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-1,3-benzothiazol-6-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-(1,3-thiazol-2-ylcarbamoyl)piperidin-3-yl]-3-(2-methylindazol-5-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(3-fluoro-3-methylazetidine-1-carbonyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide.

Molecular Properties

Compound NameN-[(3R,6S)-6-(diethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-1,3-benzothiazol-6-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-(1,3-thiazol-2-ylcarbamoyl)piperidin-3-yl]-3-(2-methylindazol-5-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(3-fluoro-3-methylazetidine-1-carbonyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide
PubChem CID158039940
Molecular FormulaC159H171F3N32O12S2
Molecular Weight2843.46 g/mol
Exact Mass2841.31
IUPAC NameN-[(3R,6S)-6-(diethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-1,3-benzothiazol-6-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-(1,3-thiazol-2-ylcarbamoyl)piperidin-3-yl]-3-(2-methylindazol-5-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(3-fluoro-3-methylazetidine-1-carbonyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide
SMILESCCN(CC)C(=O)[C@@H]1CC[C@@H](NC(=O)c2ccc3[nH]nc(-c4ccnc(C)c4)c3c2)CN1CCc1ccccc1.COc1cccc(F)c1CN1C[C@H](NC(=O)c2ccc3[nH]nc(-c4ccc5nc(C)sc5c4)c3c2)CC[C@H]1C(=O)N(C)C.COc1cccc(F)c1CN1C[C@H](NC(=O)c2ccc3[nH]nc(-c4ccc5nn(C)cc5c4)c3c2)CC[C@H]1C(=O)Nc1nccs1.Cc1cc(-c2n[nH]c3ccc(C(=O)N[C@@H]4CC[C@@H](C(=O)N(C)C)N(CCc5ccccc5)C4)cc23)ccn1.Cc1cc(-c2n[nH]c3ccc(C(=O)N[C@@H]4CC[C@@H](C(=O)N5CC(C)(F)C5)N(CCc5ccccc5)C4)cc23)ccn1
InChIInChI=1S/C33H31FN8O3S.C32H33FN6O3S.C32H35FN6O2.C32H38N6O2.C30H34N6O2/c1-41-16-21-14-19(6-9-26(21)40-41)30-23-15-20(7-10-27(23)38-39-30)31(43)36-22-8-11-28(32(44)37-33-35-12-13-46-33)42(17-22)18-24-25(34)4-3-5-29(24)45-2;1-18-34-26-12-8-19(15-29(26)43-18)30-22-14-20(9-11-25(22)36-37-30)31(40)35-21-10-13-27(32(41)38(2)3)39(16-21)17-23-24(33)6-5-7-28(23)42-4;1-21-16-23(12-14-34-21)29-26-17-24(8-10-27(26)36-37-29)30(40)35-25-9-11-28(31(41)39-19-32(2,33)20-39)38(18-25)15-13-22-6-4-3-5-7-22;1-4-37(5-2)32(40)29-14-12-26(21-38(29)18-16-23-9-7-6-8-10-23)34-31(39)25-11-13-28-27(20-25)30(36-35-28)24-15-17-33-22(3)19-24;1-20-17-22(13-15-31-20)28-25-18-23(9-11-26(25)33-34-28)29(37)32-24-10-12-27(30(38)35(2)3)36(19-24)16-14-21-7-5-4-6-8-21/h3-7,9-10,12-16,22,28H,8,11,17-18H2,1-2H3,(H,36,43)(H,38,39)(H,35,37,44);5-9,11-12,14-15,21,27H,10,13,16-17H2,1-4H3,(H,35,40)(H,36,37);3-8,10,12,14,16-17,25,28H,9,11,13,15,18-20H2,1-2H3,(H,35,40)(H,36,37);6-11,13,15,17,19-20,26,29H,4-5,12,14,16,18,21H2,1-3H3,(H,34,39)(H,35,36);4-9,11,13,15,17-18,24,27H,10,12,14,16,19H2,1-3H3,(H,32,37)(H,33,34)/t22-,28+;21-,27+;25-,28+;26-,29+;24-,27+/m11111/s1
InChIKeyFIFPFEGQJSTOPC-RCOOQGBVSA-N
XLogP23.01
TPSA516.17 Ų
H-Bond Donors11
H-Bond Acceptors31
Rotatable Bonds38
Heavy Atoms208
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002843.46
LogP ≤ 523.01
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1031

Analyze N-[(3R,6S)-6-(diethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-1,3-benzothiazol-6-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-(1,3-thiazol-2-ylcarbamoyl)piperidin-3-yl]-3-(2-methylindazol-5-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(3-fluoro-3-methylazetidine-1-carbonyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(3R,6S)-6-(diethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-1,3-benzothiazol-6-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-(1,3-thiazol-2-ylcarbamoyl)piperidin-3-yl]-3-(2-methylindazol-5-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(3-fluoro-3-methylazetidine-1-carbonyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide?
The IUPAC name of N-[(3R,6S)-6-(diethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-1,3-benzothiazol-6-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-(1,3-thiazol-2-ylcarbamoyl)piperidin-3-yl]-3-(2-methylindazol-5-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(3-fluoro-3-methylazetidine-1-carbonyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide (CID 158039940) is N-[(3R,6S)-6-(diethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-1,3-benzothiazol-6-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-(1,3-thiazol-2-ylcarbamoyl)piperidin-3-yl]-3-(2-methylindazol-5-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(3-fluoro-3-methylazetidine-1-carbonyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide.
What is the SMILES notation for N-[(3R,6S)-6-(diethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-1,3-benzothiazol-6-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-(1,3-thiazol-2-ylcarbamoyl)piperidin-3-yl]-3-(2-methylindazol-5-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(3-fluoro-3-methylazetidine-1-carbonyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide?
The canonical SMILES for N-[(3R,6S)-6-(diethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-1,3-benzothiazol-6-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-(1,3-thiazol-2-ylcarbamoyl)piperidin-3-yl]-3-(2-methylindazol-5-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(3-fluoro-3-methylazetidine-1-carbonyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide is CCN(CC)C(=O)[C@@H]1CC[C@@H](NC(=O)c2ccc3[nH]nc(-c4ccnc(C)c4)c3c2)CN1CCc1ccccc1.COc1cccc(F)c1CN1C[C@H](NC(=O)c2ccc3[nH]nc(-c4ccc5nc(C)sc5c4)c3c2)CC[C@H]1C(=O)N(C)C.COc1cccc(F)c1CN1C[C@H](NC(=O)c2ccc3[nH]nc(-c4ccc5nn(C)cc5c4)c3c2)CC[C@H]1C(=O)Nc1nccs1.Cc1cc(-c2n[nH]c3ccc(C(=O)N[C@@H]4CC[C@@H](C(=O)N(C)C)N(CCc5ccccc5)C4)cc23)ccn1.Cc1cc(-c2n[nH]c3ccc(C(=O)N[C@@H]4CC[C@@H](C(=O)N5CC(C)(F)C5)N(CCc5ccccc5)C4)cc23)ccn1.
What is the InChIKey of N-[(3R,6S)-6-(diethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-1,3-benzothiazol-6-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-(1,3-thiazol-2-ylcarbamoyl)piperidin-3-yl]-3-(2-methylindazol-5-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(3-fluoro-3-methylazetidine-1-carbonyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide?
The InChIKey is FIFPFEGQJSTOPC-RCOOQGBVSA-N. The full InChI is InChI=1S/C33H31FN8O3S.C32H33FN6O3S.C32H35FN6O2.C32H38N6O2.C30H34N6O2/c1-41-16-21-14-19(6-9-26(21)40-41)30-23-15-20(7-10-27(23)38-39-30)31(43)36-22-8-11-28(32(44)37-33-35-12-13-46-33)42(17-22)18-24-25(34)4-3-5-29(24)45-2;1-18-34-26-12-8-19(15-29(26)43-18)30-22-14-20(9-11-25(22)36-37-30)31(40)35-21-10-13-27(32(41)38(2)3)39(16-21)17-23-24(33)6-5-7-28(23)42-4;1-21-16-23(12-14-34-21)29-26-17-24(8-10-27(26)36-37-29)30(40)35-25-9-11-28(31(41)39-19-32(2,33)20-39)38(18-25)15-13-22-6-4-3-5-7-22;1-4-37(5-2)32(40)29-14-12-26(21-38(29)18-16-23-9-7-6-8-10-23)34-31(39)25-11-13-28-27(20-25)30(36-35-28)24-15-17-33-22(3)19-24;1-20-17-22(13-15-31-20)28-25-18-23(9-11-26(25)33-34-28)29(37)32-24-10-12-27(30(38)35(2)3)36(19-24)16-14-21-7-5-4-6-8-21/h3-7,9-10,12-16,22,28H,8,11,17-18H2,1-2H3,(H,36,43)(H,38,39)(H,35,37,44);5-9,11-12,14-15,21,27H,10,13,16-17H2,1-4H3,(H,35,40)(H,36,37);3-8,10,12,14,16-17,25,28H,9,11,13,15,18-20H2,1-2H3,(H,35,40)(H,36,37);6-11,13,15,17,19-20,26,29H,4-5,12,14,16,18,21H2,1-3H3,(H,34,39)(H,35,36);4-9,11,13,15,17-18,24,27H,10,12,14,16,19H2,1-3H3,(H,32,37)(H,33,34)/t22-,28+;21-,27+;25-,28+;26-,29+;24-,27+/m11111/s1.
What are the key properties of N-[(3R,6S)-6-(diethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-1,3-benzothiazol-6-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-(1,3-thiazol-2-ylcarbamoyl)piperidin-3-yl]-3-(2-methylindazol-5-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(3-fluoro-3-methylazetidine-1-carbonyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide?
N-[(3R,6S)-6-(diethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-1,3-benzothiazol-6-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-(1,3-thiazol-2-ylcarbamoyl)piperidin-3-yl]-3-(2-methylindazol-5-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(3-fluoro-3-methylazetidine-1-carbonyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide has a molecular weight of 2843.46 g/mol, XLogP of 23.01, 38 rotatable bonds, 11 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3R,6S)-6-(diethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-[(2-fluoro-6-methoxyphenyl)methyl]piperidin-3-yl]-3-(2-methyl-1,3-benzothiazol-6-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(dimethylcarbamoyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide;N-[(3R,6S)-1-[(2-fluoro-6-methoxyphenyl)methyl]-6-(1,3-thiazol-2-ylcarbamoyl)piperidin-3-yl]-3-(2-methylindazol-5-yl)-1H-indazole-5-carboxamide;N-[(3R,6S)-6-(3-fluoro-3-methylazetidine-1-carbonyl)-1-(2-phenylethyl)piperidin-3-yl]-3-(2-methyl-4-pyridinyl)-1H-indazole-5-carboxamide is sourced from PubChem (CID 158039940), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).